JP2023518777A5 - - Google Patents
Info
- Publication number
- JP2023518777A5 JP2023518777A5 JP2022556478A JP2022556478A JP2023518777A5 JP 2023518777 A5 JP2023518777 A5 JP 2023518777A5 JP 2022556478 A JP2022556478 A JP 2022556478A JP 2022556478 A JP2022556478 A JP 2022556478A JP 2023518777 A5 JP2023518777 A5 JP 2023518777A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- formula
- compound according
- compound
- independently selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020081295 | 2020-03-26 | ||
| CNPCT/CN2020/081295 | 2020-03-26 | ||
| CNPCT/CN2021/078391 | 2021-03-01 | ||
| CN2021078391 | 2021-03-01 | ||
| PCT/CN2021/083013 WO2021190601A1 (en) | 2020-03-26 | 2021-03-25 | Cyclophilin inhibitors and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023518777A JP2023518777A (ja) | 2023-05-08 |
| JP2023518777A5 true JP2023518777A5 (https=) | 2024-04-05 |
| JP7776435B2 JP7776435B2 (ja) | 2025-11-26 |
Family
ID=77891510
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022556477A Active JP7761578B2 (ja) | 2020-03-26 | 2021-03-25 | シクロスポリン誘導体の調製 |
| JP2022556478A Active JP7776435B2 (ja) | 2020-03-26 | 2021-03-25 | シクロフィリン阻害剤およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022556477A Active JP7761578B2 (ja) | 2020-03-26 | 2021-03-25 | シクロスポリン誘導体の調製 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20230174583A1 (https=) |
| EP (2) | EP4126905A4 (https=) |
| JP (2) | JP7761578B2 (https=) |
| KR (2) | KR20220158761A (https=) |
| CN (2) | CN115335389A (https=) |
| AU (1) | AU2021240762A1 (https=) |
| BR (1) | BR112022018929A2 (https=) |
| CA (2) | CA3172601A1 (https=) |
| IL (1) | IL296586B1 (https=) |
| MX (1) | MX2022011697A (https=) |
| WO (2) | WO2021190601A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111449050A (zh) * | 2019-01-20 | 2020-07-28 | 睿诺医疗科技（上海）有限公司 | 环孢菌素类似物及其用途 |
| AU2020363688A1 (en) | 2019-10-12 | 2022-04-21 | Farsight Medical Technology (Shanghai) Co., Ltd. | Treatment and prevention of nephrotoxin-induced kidney injuries |
| IL296586B1 (en) * | 2020-03-26 | 2026-04-01 | Farsight Medical Tech Shanghai Co Ltd | Cyclophilin inhibitors and their uses |
| AU2021256222A1 (en) | 2020-04-15 | 2022-10-06 | Farsight Medical Technology (Shanghai) Co., Ltd. | Prevention and treatment of organ injuries |
| GB202207348D0 (en) * | 2022-05-19 | 2022-07-06 | Cypralis Ltd | Macrocyclic compounds and uses thereof |
| WO2024183651A1 (en) * | 2023-03-03 | 2024-09-12 | Farsight Medical Technology (Shanghai) Co., Ltd. | Treatment and prevention of agent‐induced liver conditions or diseases |
| KR20260018851A (ko) * | 2023-06-02 | 2026-02-09 | 파사이트 메디컬 테크놀로지 (상하이) 컴퍼니 리미티드 | 사이클로필린 저해제 및 그 용도 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0194972B1 (en) | 1985-03-11 | 1992-07-29 | Sandoz Ag | Novel cyclosporins |
| FI111730B (fi) | 1990-11-02 | 2003-09-15 | Novartis Ag | Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi |
| AU750245B2 (en) * | 1997-10-08 | 2002-07-11 | Aurinia Phamaceuticals Inc. | Deuterated cyclosporine analogs and their use as immunomodulating agents |
| CN1205220C (zh) | 1998-06-12 | 2005-06-08 | 斯－凯穆公司 | 新颖的环孢菌素 |
| US6809077B2 (en) | 2001-10-12 | 2004-10-26 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogs for the treatment of autoimmune diseases |
| CN100344648C (zh) | 2001-10-19 | 2007-10-24 | 伊索泰克尼卡股份有限公司 | 环孢菌素类似物混合物及其在制备免疫调节剂中的用途 |
| US7538084B2 (en) | 2003-03-17 | 2009-05-26 | Amr Technology, Inc. | Cyclosporins |
| SI1802650T1 (sl) | 2004-10-01 | 2012-03-30 | Scynexis Inc | Eter in tioeter substituirani ciklosporinski derivati za zdravljenje in preventivo pred infekcijami s hepatitisom c |
| ZA200703157B (en) * | 2004-10-01 | 2008-08-27 | Scynexis Inc | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection |
| EP2023918B1 (en) * | 2006-05-19 | 2011-03-23 | Scynexis, Inc. | Cyclosporins for the treatment and prevention of ocular disorders |
| WO2008143996A1 (en) * | 2007-05-18 | 2008-11-27 | Scynexis, Inc. | New chemical processes |
| AU2009276241A1 (en) | 2008-07-30 | 2010-02-04 | Ciclofilin Pharmaceuticals Corp. | Nonimmunosuppressive cyclosporine analogue molecules |
| KR20110111321A (ko) * | 2009-01-30 | 2011-10-10 | 이난타 파마슈티칼스, 인코포레이티드 | Ｃ형 간염을 예방하거나 치료하기 위한 사이클로스포린 유사체 |
| US8481483B2 (en) | 2009-02-19 | 2013-07-09 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
| WO2011082289A1 (en) * | 2009-12-30 | 2011-07-07 | Scynexis Inc. | Cyclosporine analogues |
| WO2012009715A2 (en) * | 2010-07-16 | 2012-01-19 | S&T Global Inc. | Novel cyclosporin derivatives for the treatment and prevention of a viral infection |
| US9890198B2 (en) * | 2010-12-03 | 2018-02-13 | S&T Global Inc. | Cyclosporin derivatives and uses thereof |
| BR112013014890B1 (pt) | 2010-12-15 | 2023-10-24 | Contravir Pharmaceuticals, Inc | Composto análogo de moléculas pertencentes à família ciclosporina, composição farmacêutica compreendendo o mesmo, uso terapêutico ou profilático do referido composto e processos para a preparação dos mesmos |
| DE102011111991A1 (de) * | 2011-08-30 | 2013-02-28 | Lead Discovery Center Gmbh | Neue Cyclosporin-Derivate |
| GB201217560D0 (en) | 2012-10-02 | 2012-11-14 | Mitopharm Ltd | Novel cyclic depsipeptide compounds and their uses |
| US20140212381A1 (en) * | 2012-10-19 | 2014-07-31 | Scynexis, Inc. | Macrocycles |
| GB201222455D0 (en) * | 2012-12-13 | 2013-01-30 | Perioc Ltd | Novel pharmaceutical formulations and their use in the treatment of periodontaldisease |
| GB201414806D0 (en) | 2014-08-20 | 2014-10-01 | Ucl Business Plc | Cyclosporin conjugates |
| WO2017004304A1 (en) * | 2015-06-30 | 2017-01-05 | Cypralis Limited | Novel macrocycles |
| CN106902346A (zh) * | 2015-12-23 | 2017-06-30 | 中美华世通生物医药科技（武汉）有限公司 | 药物组合物及其制药用途 |
| CN106902347A (zh) * | 2015-12-23 | 2017-06-30 | 中美华世通生物医药科技（武汉）有限公司 | 亲环孢素抑制剂的用途 |
| CN118324867A (zh) * | 2016-05-17 | 2024-07-12 | 美国科技环球有限公司 | 新型环孢菌素衍生物及其用途 |
| GB201711749D0 (en) * | 2017-07-21 | 2017-09-06 | Cypralis Ltd | Cyclosporin analogues and uses thereof |
| WO2020037530A1 (en) * | 2018-08-22 | 2020-02-27 | Waterstone Pharmaceuticals (Wuhan) Co., Ltd. | Crystalline form of compound and uses thereof in medicine |
| CN111449050A (zh) * | 2019-01-20 | 2020-07-28 | 睿诺医疗科技（上海）有限公司 | 环孢菌素类似物及其用途 |
| IL296586B1 (en) * | 2020-03-26 | 2026-04-01 | Farsight Medical Tech Shanghai Co Ltd | Cyclophilin inhibitors and their uses |
-
2021
- 2021-03-24 IL IL296586A patent/IL296586B1/en unknown
- 2021-03-25 KR KR1020227036440A patent/KR20220158761A/ko active Pending
- 2021-03-25 JP JP2022556477A patent/JP7761578B2/ja active Active
- 2021-03-25 CN CN202180023394.0A patent/CN115335389A/zh active Pending
- 2021-03-25 EP EP21776894.4A patent/EP4126905A4/en active Pending
- 2021-03-25 KR KR1020227036439A patent/KR20220158760A/ko active Pending
- 2021-03-25 WO PCT/CN2021/083013 patent/WO2021190601A1/en not_active Ceased
- 2021-03-25 BR BR112022018929A patent/BR112022018929A2/pt unknown
- 2021-03-25 EP EP21776582.5A patent/EP4126904A4/en active Pending
- 2021-03-25 JP JP2022556478A patent/JP7776435B2/ja active Active
- 2021-03-25 CN CN202180023172.9A patent/CN115298199A/zh active Pending
- 2021-03-25 WO PCT/CN2021/083016 patent/WO2021190604A1/en not_active Ceased
- 2021-03-25 MX MX2022011697A patent/MX2022011697A/es unknown
- 2021-03-25 CA CA3172601A patent/CA3172601A1/en active Pending
- 2021-03-25 CA CA3172535A patent/CA3172535A1/en active Pending
- 2021-03-25 AU AU2021240762A patent/AU2021240762A1/en active Pending
- 2021-03-25 US US17/906,348 patent/US20230174583A1/en active Pending
-
2022
- 2022-09-16 US US17/946,071 patent/US12060440B2/en active Active
-
2024
- 2024-06-26 US US18/754,189 patent/US12522634B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023518777A5 (https=) | ||
| JP7067792B2 (ja) | 新たなピラジン誘導体及びその調製方法並びに医薬応用 | |
| JP2013500314A5 (https=) | ||
| CA2691446A1 (en) | Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses | |
| JP6628252B2 (ja) | 虚血性眼疾患の処置用の医薬組成物 | |
| JP2023518775A5 (https=) | ||
| CN104083385B (zh) | 闭花木酮Cleistanone的O-(哌啶基)乙基衍生物在制备升高白细胞的药物中的应用 | |
| JP2017522304A5 (https=) | ||
| CN108239095A (zh) | 一类吡喃并咔唑生物碱及其制备方法和其药物组合物与用途 | |
| HU202106B (en) | Process for producing pharmaceutical compositions containing pyrazolin derivatives | |
| FR3107897A1 (fr) | Dérivés de nicotinamide mononucléotides | |
| RU2770033C2 (ru) | Композиции и способы лечения инфекционных заболеваний ротовой полости | |
| JP2012518671A5 (https=) | ||
| JP2020511437A5 (https=) | ||
| CN103396368B (zh) | 氮氧自由基在治疗缺血再灌注损伤中的应用 | |
| JPS60158149A (ja) | 炎症抑制作用を有する１，４‐ナフトキノン誘導体 | |
| RU2002102495A (ru) | Новые производные ксантона, их получение и применение в качестве лекарственного средства | |
| CN110372614A (zh) | 一种四氢喹喔啉类化合物及制备方法与应用 | |
| CN109180712B (zh) | 一类2-茨醇的芳基硼酸酯衍生物及其应用 | |
| WO2016184122A1 (zh) | 一种吡唑类化合物 | |
| CN117327028B (zh) | 吩噻嗪类衍生物、药物组合物及其在治疗棘球蚴病中的用途 | |
| CN115504902A (zh) | 5-氯水杨酰胺类衍生物、其制备方法及其作为药物的用途 | |
| JP2021024835A (ja) | 小腸潰瘍改善剤 | |
| JP2007516980A (ja) | ２つの金（ｉ）原子が該２つの金（ｉ）原子を接続している共有リンクにおいてそれぞれ炭素原子に共有結合された化合物の、癌の治療のための使用 | |
| JP7426756B2 (ja) | チオベンゾピラン系化合物及び関節リウマチの治療薬の調製におけるその使用 |